These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 22399594
1. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594 [Abstract] [Full Text] [Related]
2. Detection of TFPI2 methylation in the serum of colorectal cancer patients. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y. Cancer Lett; 2011 Dec 01; 311(1):96-100. PubMed ID: 21820798 [Abstract] [Full Text] [Related]
3. Detection of TFPI2 methylation in the serum of gastric cancer patients. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2011 Nov 01; 31(11):3835-8. PubMed ID: 22110206 [Abstract] [Full Text] [Related]
4. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer. Hibi K, Goto T, Kitamura YH, Yokomizo K, Sakuraba K, Shirahata A, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2010 Apr 01; 30(4):1205-7. PubMed ID: 20530429 [Abstract] [Full Text] [Related]
5. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. Zhang J, Yang S, Xie Y, Chen X, Zhao Y, He D, Li J. Cancer Epidemiol; 2012 Feb 01; 36(1):73-7. PubMed ID: 21621497 [Abstract] [Full Text] [Related]
6. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Nishio M, Sakakura C, Nagata T, Komiyama S, Miyashita A, Hamada T, Kuryu Y, Ikoma H, Kubota T, Kimura A, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Ida H, Ito K, Chiba T, Ito Y, Otsuji E. Anticancer Res; 2010 Jul 01; 30(7):2673-82. PubMed ID: 20682997 [Abstract] [Full Text] [Related]
7. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients. Hibi K, Mizukami H, Saito M, Kigawa G, Nemoto H. Hepatogastroenterology; 2014 Jul 01; 61(130):354-6. PubMed ID: 24901139 [Abstract] [Full Text] [Related]
8. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer. Harada Y, Kijima K, Shinmura K, Sakata M, Sakuraba K, Yokomizo K, Kitamura Y, Shirahata A, Goto T, Mizukami H, Saito M, Kigawa G, Nemoto H, Hibi K. Anticancer Res; 2011 Sep 01; 31(9):2889-92. PubMed ID: 21868534 [Abstract] [Full Text] [Related]
9. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer. Morioka Y, Hibi K, Sakai M, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Anticancer Res; 2006 Sep 01; 26(6B):4267-70. PubMed ID: 17201143 [Abstract] [Full Text] [Related]
11. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, Göke B, Lamerz R, Kolligs FT. Clin Cancer Res; 2006 Dec 15; 12(24):7347-52. PubMed ID: 17189406 [Abstract] [Full Text] [Related]
12. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer. Hibi K, Mizukami H, Shirahata A, Goto T, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2009 Jan 15; 29(1):271-3. PubMed ID: 19331160 [Abstract] [Full Text] [Related]
13. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Sakakura C, Hamada T, Miyagawa K, Nishio M, Miyashita A, Nagata H, Ida H, Yazumi S, Otsuji E, Chiba T, Ito K, Ito Y. Anticancer Res; 2009 Jul 15; 29(7):2619-25. PubMed ID: 19596937 [Abstract] [Full Text] [Related]
14. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A, Takahata T, Saito M, Yoshiya G, Tamura Y, Sasaki M, Munakata A. J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1334-9. PubMed ID: 16872319 [Abstract] [Full Text] [Related]
15. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T. Cancer Genet Cytogenet; 2010 Feb 15; 197(1):16-24. PubMed ID: 20113832 [Abstract] [Full Text] [Related]
16. p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer. Nakayama G, Kodera Y, Ohashi N, Koike M, Fujiwara M, Nakao A. Anticancer Res; 2011 May 15; 31(5):1643-6. PubMed ID: 21617221 [Abstract] [Full Text] [Related]
17. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Goto T, Mizukami H, Shirahata A, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K. Anticancer Res; 2009 Jan 15; 29(1):275-7. PubMed ID: 19331161 [Abstract] [Full Text] [Related]
18. FBN2 methylation is detected in the serum of colorectal cancer patients with hepatic metastasis. Hibi K, Mizukami H, Saito M, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2012 Oct 15; 32(10):4371-4. PubMed ID: 23060561 [Abstract] [Full Text] [Related]
19. Vimentin methylation as a marker for advanced colorectal carcinoma. Shirahata A, Sakata M, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K. Anticancer Res; 2009 Jan 15; 29(1):279-81. PubMed ID: 19331162 [Abstract] [Full Text] [Related]
20. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients. Nakayama G, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A. Anticancer Res; 2007 Jan 15; 27(3B):1459-63. PubMed ID: 17595762 [Abstract] [Full Text] [Related] Page: [Next] [New Search]